We are live on ! Find out more
RNTX

Rein Therapeutics
RNTX

47 hedge funds and large institutions have $41.5M invested in Rein Therapeutics in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.02% less ownership

Funds ownership: 1.86% → 1.84% (-0.02%)

10% less funds holding

Funds holding: 52 → 47 (-5)

13% less capital invested

Capital invested by funds: $48M → $41.5M (-$6.46M)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

Holders
47
Holders Change
-5
Holders Change %
-9.62%
% of All Funds
0.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
14
Reduced
8
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
+$427K
2
BlackRock
BlackRock
New York
+$248K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$243K
4
State Street
State Street
Massachusetts
+$88.8K
5
Millennium Management
Millennium Management
New York
+$77.1K

Top Sellers

Rank Fund Capital Flow
1
MS
Maven Securities
Jersey
-$700K
2
Renaissance Technologies
Renaissance Technologies
New York
-$274K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$269K
4
VF
Virtu Financial
New York
-$209K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$192K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$35K – – –
HBWM
27
Hollow Brook Wealth Management
New York
$31K – – –
US Bancorp
28
US Bancorp
Minnesota
$31K – – –
ECM
29
ExodusPoint Capital Management
New York
$29K +$28.8K +1,155 New
CS
30
Candriam SCA
Luxembourg
$28K +$28.1K +1,128 New
Mercer Global Advisors
31
Mercer Global Advisors
Colorado
$26K +$50 +2 +0.2%
Bank Julius Baer & Co
32
Bank Julius Baer & Co
Switzerland
$25K – – –
LSAG
33
Lake Street Advisors Group
New Hampshire
$20K +$6.24K +250 +37%
PAM
34
PVG Asset Management
Colorado
$18.8K +$798 +32 +4%
Bank of America
35
Bank of America
North Carolina
$15K +$1.15K +46 +9%
UBS Group
36
UBS Group
Switzerland
$15K +$11.9K +476 +437%
KPW
37
Kore Private Wealth
New York
$14K – – –
MIH
38
Meitav Investment House
Israel
$14K – – –
Victory Capital Management
39
Victory Capital Management
Texas
$13K -$574 -23 -4%
Commonwealth Equity Services
40
Commonwealth Equity Services
Massachusetts
$13K – – –
RWP
41
Ridgecrest Wealth Partners
California
$13K – – –
Osaic Holdings
42
Osaic Holdings
Arizona
$13K +$6.31K +253 +96%
Barclays
43
Barclays
United Kingdom
$9K -$5.12K -205 -35%
TRCT
44
Tower Research Capital (TRC)
New York
$3K +$3.39K +136 New
AF
45
Allworth Financial
California
$1K – – –
JCM
46
Jacobi Capital Management
Pennsylvania
$1K – – –
Wells Fargo
47
Wells Fargo
California
$1K +$50 +2 +10%
MS
48
Maven Securities
Jersey
– -$700K -25,000 Closed
VF
49
Virtu Financial
New York
– -$209K -7,317 Closed
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
– -$192K -6,721 Closed
1
2
3

RNTX Hedge Fund Activity: Q2 2021 in Review

47 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q2 2021, worth a combined $41.5M — down 13% from $48M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RNTX and 6 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 14 added.

The largest buyer was William Blair & Company, adding an estimated $427K. The largest seller was Maven Securities, exiting entirely with an estimated $700K sold.

  • 47 institutional investors held Rein Therapeutics (RNTX) as of Q2 2021, down from 52 in Q1 2021.
  • Funds reported $41.5M of Rein Therapeutics stock for Q2 2021, down 13% quarter-over-quarter.
  • 6 funds opened new Rein Therapeutics positions in Q2 2021 and 10 closed out, a net change of -4 holders.
  • The largest Rein Therapeutics buyer in Q2 2021 was William Blair & Company, an estimated $427K added.
  • The largest Rein Therapeutics seller in Q2 2021 was Maven Securities, an estimated $700K sold.

Based on aggregated 13F filings for Q2 2021.